This inventor holds 1 USPTO granted patent. Top assignee: Exelixis, Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Lisa E Meyr: Innovator in JAK-2 Modulation
Introduction
Lisa E Meyr is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of pharmacology, particularly in the development of JAK-2 modulators. Her innovative work has led to the creation of a patent that addresses important therapeutic needs.
Latest Patents
Lisa holds a patent for "4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use." This invention relates to certain pyrimidine derivative inhibitors of JAK-2, which are crucial in treating various diseases. The patent includes pharmaceutically acceptable salts, pharmaceutical compositions, and methods of use, showcasing her expertise in medicinal chemistry.
Career Highlights
Lisa is currently associated with Exelixis, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in the discovery of new therapeutic agents that target JAK-2, a key player in several inflammatory and autoimmune conditions.
Collaborations
Lisa collaborates with talented professionals in her field, including Grace Mann and Naing N Aay. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Lisa E Meyr is a dedicated inventor whose work in JAK-2 modulation has the potential to impact the pharmaceutical industry significantly. Her innovative spirit and collaborative efforts continue to drive advancements in medical science.